538 related articles for article (PubMed ID: 36059592)
1. Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis.
Beck LA; Cork MJ; Amagai M; De Benedetto A; Kabashima K; Hamilton JD; Rossi AB
JID Innov; 2022 Sep; 2(5):100131. PubMed ID: 36059592
[TBL] [Abstract][Full Text] [Related]
2. Epidermal tight junctions in health and disease.
Brandner JM; Zorn-Kruppa M; Yoshida T; Moll I; Beck LA; De Benedetto A
Tissue Barriers; 2015; 3(1-2):e974451. PubMed ID: 25838981
[TBL] [Abstract][Full Text] [Related]
3. Topical corticosteroids normalize both skin and systemic inflammatory markers in infant atopic dermatitis.
McAleer MA; Jakasa I; Stefanovic N; McLean WHI; Kezic S; Irvine AD
Br J Dermatol; 2021 Jul; 185(1):153-163. PubMed ID: 33269467
[TBL] [Abstract][Full Text] [Related]
4. Children with atopic dermatitis show increased activity of β-glucocerebrosidase and stratum corneum levels of glucosylcholesterol that are strongly related to the local cytokine milieu.
Kezic S; McAleer MA; Jakasa I; Goorden SMI; der Vlugt KG; Beers-Stet FS; Meijer J; Roelofsen J; Nieman MM; van Kuilenburg ABP; Irvine AD
Br J Dermatol; 2022 Jun; 186(6):988-996. PubMed ID: 34993951
[TBL] [Abstract][Full Text] [Related]
5. Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17.
Yuki T; Tobiishi M; Kusaka-Kikushima A; Ota Y; Tokura Y
PLoS One; 2016; 11(9):e0161759. PubMed ID: 27588419
[TBL] [Abstract][Full Text] [Related]
6. Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair.
Kuo IH; Carpenter-Mendini A; Yoshida T; McGirt LY; Ivanov AI; Barnes KC; Gallo RL; Borkowski AW; Yamasaki K; Leung DY; Georas SN; De Benedetto A; Beck LA
J Invest Dermatol; 2013 Apr; 133(4):988-98. PubMed ID: 23223142
[TBL] [Abstract][Full Text] [Related]
7. The immunological and structural epidermal barrier dysfunction and skin microbiome in atopic dermatitis-an update.
Çetinarslan T; Kümper L; Fölster-Holst R
Front Mol Biosci; 2023; 10():1159404. PubMed ID: 37654796
[TBL] [Abstract][Full Text] [Related]
8. Pyrrolidone carboxylic acid levels or caspase-14 expression in the corneocytes of lesional skin correlates with clinical severity, skin barrier function and lesional inflammation in atopic dermatitis.
Jung M; Choi J; Lee SA; Kim H; Hwang J; Choi EH
J Dermatol Sci; 2014 Dec; 76(3):231-9. PubMed ID: 25315296
[TBL] [Abstract][Full Text] [Related]
9. Th2 Cytokines Affect the Innate Immune Barrier without Impairing the Physical Barrier in a 3D Model of Normal Human Skin.
Donetti E; Riva F; Indino S; Lombardo G; Baruffaldi Preis F; Rosi E; Prignano F
J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902728
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of Aquaphilus dolomiae extract-G1, ADE-G1, on tight junction barrier function in a Staphylococcus aureus-infected atopic dermatitis model.
Galliano MF; Bäsler K; Caruana A; Mias C; Bessou-Touya S; Brandner JM; Duplan H
J Eur Acad Dermatol Venereol; 2020 Aug; 34 Suppl 5():30-36. PubMed ID: 32870557
[TBL] [Abstract][Full Text] [Related]
11. Human β-defensin-3 attenuates atopic dermatitis-like inflammation through autophagy activation and the aryl hydrocarbon receptor signaling pathway.
Peng G; Tsukamoto S; Ikutama R; Nguyen HLT; Umehara Y; Trujillo-Paez JV; Yue H; Takahashi M; Ogawa T; Kishi R; Tominaga M; Takamori K; Kitaura J; Kageyama S; Komatsu M; Okumura K; Ogawa H; Ikeda S; Niyonsaba F
J Clin Invest; 2022 Sep; 132(17):. PubMed ID: 35834333
[TBL] [Abstract][Full Text] [Related]
12. Human β-defensin-2 as a marker for disease severity and skin barrier properties in atopic dermatitis.
Clausen ML; Jungersted JM; Andersen PS; Slotved HC; Krogfelt KA; Agner T
Br J Dermatol; 2013 Sep; 169(3):587-93. PubMed ID: 23647067
[TBL] [Abstract][Full Text] [Related]
13. Stratum corneum markers of innate and T helper cell-related immunity and their relation to the disease severity in Croatian patients with atopic dermatitis.
Jurakic Toncic R; Jakasa I; Sun Y; Hurault G; Ljubojevic Hadzavdic S; Tanaka RJ; Pavicic B; Balic A; Zuzul K; Petkovic M; Kezic S; Marinovic B
J Eur Acad Dermatol Venereol; 2021 May; 35(5):1186-1196. PubMed ID: 33480075
[TBL] [Abstract][Full Text] [Related]
14. Systemic and stratum corneum biomarkers of severity in infant atopic dermatitis include markers of innate and T helper cell-related immunity and angiogenesis.
McAleer MA; Jakasa I; Hurault G; Sarvari P; McLean WHI; Tanaka RJ; Kezic S; Irvine AD
Br J Dermatol; 2019 Mar; 180(3):586-596. PubMed ID: 30132823
[TBL] [Abstract][Full Text] [Related]
15. Host defense (Antimicrobial) peptide, human β-defensin-3, improves the function of the epithelial tight-junction barrier in human keratinocytes.
Kiatsurayanon C; Niyonsaba F; Smithrithee R; Akiyama T; Ushio H; Hara M; Okumura K; Ikeda S; Ogawa H
J Invest Dermatol; 2014 Aug; 134(8):2163-2173. PubMed ID: 24633129
[TBL] [Abstract][Full Text] [Related]
16. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency.
Kezic S; O'Regan GM; Lutter R; Jakasa I; Koster ES; Saunders S; Caspers P; Kemperman PM; Puppels GJ; Sandilands A; Chen H; Campbell LE; Kroboth K; Watson R; Fallon PG; McLean WH; Irvine AD
J Allergy Clin Immunol; 2012 Apr; 129(4):1031-9.e1. PubMed ID: 22322004
[TBL] [Abstract][Full Text] [Related]
17. Counterregulation between thymic stromal lymphopoietin- and IL-23-driven immune axes shapes skin inflammation in mice with epidermal barrier defects.
Li J; Leyva-Castillo JM; Hener P; Eisenmann A; Zaafouri S; Jonca N; Serre G; Birling MC; Li M
J Allergy Clin Immunol; 2016 Jul; 138(1):150-161.e13. PubMed ID: 26993035
[TBL] [Abstract][Full Text] [Related]
18. Activated Protein C Protects against Murine Contact Dermatitis by Suppressing Protease-Activated Receptor 2.
Xue M; Lin H; Zhao R; Fryer C; March L; Jackson CJ
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008942
[TBL] [Abstract][Full Text] [Related]
19. Epidermal tight junction barrier function is altered by skin inflammation, but not by filaggrin-deficient stratum corneum.
Yokouchi M; Kubo A; Kawasaki H; Yoshida K; Ishii K; Furuse M; Amagai M
J Dermatol Sci; 2015 Jan; 77(1):28-36. PubMed ID: 25511077
[TBL] [Abstract][Full Text] [Related]
20. IL-13 modulates ∆Np63 levels causing altered expression of barrier- and inflammation-related molecules in human keratinocytes: A possible explanation for chronicity of atopic dermatitis.
Kubo T; Sato S; Hida T; Minowa T; Hirohashi Y; Tsukahara T; Kanaseki T; Murata K; Uhara H; Torigoe T
Immun Inflamm Dis; 2021 Sep; 9(3):734-745. PubMed ID: 33792188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
